FibroGen, Inc.

FGEN
Delayed Nasdaq - 12/13 10:00:00 pm
46.69USD
-1.99%
Upcoming events on FIBROGEN, INC.
02/26/20 FY 2019 Earnings Release (Projected)
05/06/20 Q1 2020 Earnings Release (Projected)
08/10/20 Interim 2020 Earnings Release (Projected)
11/04/20 Q3 2020 Earnings Release (Projected)
Past events on FIBROGEN, INC.
11/11/19 | 05:00pmQ3 2019 Earnings Call
11/11/19 | 04:01pmQ3 2019 Earnings Release
11/09/19 | 10:00amAmerican Society of Nephrology Kidney Meeting - SA-PO228
11/09/19 | 10:00amAmerican Society of Nephrology Kidney Meeting - SA- PO226
Upcoming sector events for FIBROGEN, INC.
12/17/19 REGENERON PHARMACEUTICALS INC : Non Deal Roadshow - Evercore ISI
12/27/19 | 08:30am BEIGENE LTD : Extraordinary Shareholders Meeting
01/13/20 GENMAB A/S : JP Morgan Health Care Conference
01/13/20 | 11:30am INCYTE CORPORATION : J. P. Morgan Healthcare Conference
Past sector events for FIBROGEN, INC.
12/13/19 | 11:00amIONIS PHARMACEUTICALS, INC. : Business Update Call
12/11/19SEATTLE GENETICS, INC. : San Antonio Breast Cancer Symposium
12/11/19LONZA GROUP LTD : Roadshow - Basel
12/10/19 | 11:00pmARROWHEAD PHARMACEUTICALS, INC. : HEP Dart Conference
Annual results
Annual results20182019 (e)
Sales
M $
Released
Forecast
Spread
213
177
20%

299
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-80,1
-82,6
2,9%

-6,18
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-86,7
-113
23%

-22,4
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-86,1
-109
21%

-19,1
Net income
M $
Released
Forecast
Spread
-86,4
-110
21%

-19,5
EPS
 $
Released
Forecast
Spread
-1,03
-1,31
21%

-0,22
Announcement Date02/27/2019

Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise